Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRASTUZUMAB-ANNS Cause Product substitution issue? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product substitution issue have been filed in association with TRASTUZUMAB-ANNS. This represents 0.4% of all adverse event reports for TRASTUZUMAB-ANNS.

5
Reports of Product substitution issue with TRASTUZUMAB-ANNS
0.4%
of all TRASTUZUMAB-ANNS reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product substitution issue From TRASTUZUMAB-ANNS?

Of the 5 reports.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB-ANNS. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TRASTUZUMAB-ANNS Cause?

Product storage error (346) Circumstance or information capable of leading to medication error (257) Off label use (104) Intercepted product administration error (89) Product dose omission issue (68) Chills (58) Dyspnoea (52) Nausea (49) Diarrhoea (48) Rash (45)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which TRASTUZUMAB-ANNS Alternatives Have Lower Product substitution issue Risk?

TRASTUZUMAB-ANNS vs TRASTUZUMAB DERUXTECAN TRASTUZUMAB-ANNS vs TRASTUZUMAB-DKST TRASTUZUMAB-ANNS vs TRASTUZUMAB-DTTB TRASTUZUMAB-ANNS vs TRASTUZUMAB EMTANSINE TRASTUZUMAB-ANNS vs TRASTUZUMAB-PKRB

Related Pages

TRASTUZUMAB-ANNS Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue TRASTUZUMAB-ANNS Demographics